Skip to main content
MYUNGMOON PHARM CO.,LTD logo

MYUNGMOON PHARM CO.,LTD — Investor Relations & Filings

Ticker · 017180 ISIN · KR7017180001 KO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2020-06-26 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 017180

About MYUNGMOON PHARM CO.,LTD

http://mmpharm.co.kr/en/main/

Myungmoon Pharm Co., Ltd. is a research-based pharmaceutical company engaged in the development, manufacturing, and commercialization of healthcare products. The company produces over 250 specialized and general medicines, holding more than 400 manufacturing licenses. Its portfolio includes both ethical (ETC) and over-the-counter (OTC) drugs, with key product areas in anesthetics, digestive agents, and antitussives. The company's operations encompass the wholesale, import, and export of its pharmaceutical products for domestic and international markets.

Recent filings

Filing Released Lang Actions
유상증자또는주식관련사채등의발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement regarding the results of a capital increase (paid-in capital increase/rights offering) by Myungmoon Pharm. It details the number of shares issued, the amount raised, and the payment completion date. This falls under the category of share issuance and capital changes.
2020-06-26 Korean
[기재정정]증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed by Myungmoon Pharm Co., Ltd. This document details the final results of a capital increase (rights offering), including subscription status, allocation, and changes in major shareholdings. According to the provided filing definitions, announcements regarding new share issues or capital changes are classified as 'SHA'.
2020-06-26 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from Myungmoon Pharm regarding the results of a paid-in capital increase (rights offering). It details the subscription results, including the number of shares subscribed, the subscription rate (103.81%), and the handling of fractional shares. This falls under the category of capital structure changes and share issuance updates.
2020-06-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements of major shareholders (Woo Seok-min and related parties) in Myungmoon Pharm Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-06-22 Korean
유상증자신주발행가액(안내공시)
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Myungmoon Pharm regarding the 'fixed issue price' for a paid-in capital increase (rights offering). It details the calculation methodology for the new share price and confirms the final price per share. This falls under capital structure changes and financing updates, specifically related to share issuance pricing.
2020-06-16 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a capital increase (유상증자결정) for Myungmoon Pharm. It details the correction of the issuance price and the purpose of the funds. Since this is a formal regulatory filing detailing a capital change (share issuance) and not a mere announcement of a report, it falls under the 'Share Issue/Capital Change' category.
2020-06-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.